NEW YORK (GenomeWeb) – Over the past few years, sensitivity problems in the prostate-specific antigen screening test have led the US Preventive Task Force to rate the test a "D" as an indicator of possible prostate cancer, causing some insurers to revoke coverage. Now, a large genome-wide association study from the University of California, San Francisco and Kaiser Permanente suggests the test might be improved by taking into account natural genetic variation in PSA levels.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.

Sponsored by

This webinar will discuss the benefits of using unique molecular indices to overcome some challenges associated with next-generation sequencing panels.

Sponsored by
Agilent Technologies

This webinar will discuss a molecular barcode-based error correction method that enables combined mutation detection and DNA copy number profiling through circulating tumor DNA sequencing.